StockWatch
·
Biotechnology
Dividend19 May 2026, 07:51 pm

Anthem Biosciences Recommends ₹2 Dividend; Approves ESOP Allotment

AI Summary

Anthem Biosciences Ltd's board meeting on May 19, 2026, approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹2.00 per equity share. The board also approved the allotment of 14,81,250 equity shares under the Anthem Employee Stock Option Plan 2024, increasing the paid-up equity share capital. The 20th Annual General Meeting is scheduled for July 22, 2026. The board approved the re-appointment of internal auditors and recommended the continuation and re-appointment of certain directors, subject to shareholder approval.

Key Highlights

  • Final dividend of ₹2.00 per share recommended, subject to shareholder approval.
  • 14,81,250 equity shares allotted under Anthem Employee Stock Option Plan 2024.
  • 20th Annual General Meeting scheduled for July 22, 2026.
  • Re-appointment of M/s. BPU & Co. as Internal Auditor approved.
  • Continuation of Mr. Ravikant Uppal and re-appointment of Mr. Ravindra Chandrappa as directors recommended.